Evidence Hub

Efficacy and Safety of Vonoprazan-Based Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Meta-Analysis

Dong Saishu, Xiong Zhenggui, Yang Dingrong, Liutao Liutao

Asia Pacific Journal of Clinical Medical Research, 2025

Abstract

Aims: To compare the efcacy and safety of vonoprazan-based bismuth-containing quadruple therapy(VBCQ) versus proton pump inhibitor (PPI)-based Bismuth-Containing quadruple Therapy(PBCQ) for Helicobacter pylori eradication. Methods: We performed a systematic search in Pubmed, Embase,web of science,Cochrane Library,CNKI,Wanfang databases for relevant randomized controlled trials up to March 2019.Meta-analysis by RevMan 5. 4 software. Results: 10 randomized controlled trials were evaluated in this meta-analysis. In intention-to-treat (ITT) analysis and per-protocol(PP) analysis, the eradication rate of VBCQ was significantly higher than PBCQ [ITT overall eradication rate: 86.7% vs 82.8%, RR: 1.05,95% CI (1.05, 1.09), P 0.05). Conclusions: VBCQ has a higher eradication rate and comparable safety.

How strong is the evidence?

Evidence Hub reads this as a meta-analysis. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free